A股異動丨利亞德漲8.31% 增資3家子公司推進3大項目建設
格隆匯12月16日丨利亞德(300296.SZ)漲8.31%,報7.17元,總市值182億元。利亞德上週宣佈擬公開發行8億元可轉換公司債券。為推進公司募集資金投資項目“LED應用產業南方總部項目”、“LED應用產業園建設項目”、“利亞德(西安)智能研發中心項目”的順利實施,公司擬使用募集資金以增資方式向全資子公司深圳利亞德、利亞德電視、西安智能進行增資,用於募集資金投資項目的實施和建設。本次使用募集資金對子公司的增資,有利於保障募投項目的順利實施。可促進子公司生產經營的發展以及經營效益的提升,增強子公司的持續經營能力
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.